Key result
The rs11572377 variant in the EDN2 gene was associated with higher phenylephrine infusion rates and differentiated patients resistant to phenylephrine from sensitive patients.
Why the study?
Differences in responsiveness to phenylephrine for hypotension during anesthesia are common, and candidate gene studies indicate genetic variants may contribute to this variable response.
Do genetic variants affect phenylephrine infusion rates and responsiveness during anesthesia?
Observational (n=4,033)
Yes
Do genetic variants affect phenylephrine infusion rates and responsiveness during anesthesia?
Genetic variants, particularly rs11572377 in the EDN2 gene, may contribute to variable sensitivity and resistance to phenylephrine infusion during anesthesia.
Answers are grounded in this paper and cite their sources.
rs11572377 may identify phenylephrine-resistant patients during anesthesia; hypothesis-generating and requires prospective validation before clinical use.
The alpha-adrenergic agonist phenylephrine is often used to treat hypotension during anesthesia. In clinical situations, low blood pressure may require prompt intervention by intravenous bolus or infusion. Differences in responsiveness to phenylephrine treatment are commonly observed in clinical practice. Candidate gene studies indicate genetic variants may contribute to this variable response. Pharmacological and physiological data were retrospectively extracted from routine clinical anesthetic records. Response to phenylephrine boluses could not be reliably assessed, so infusion rates were used for analysis. Unsupervised k -means clustering was conducted on clean data containing 4130 patients based on phenylephrine infusion rate and blood pressure parameters, to identify potential phenotypic subtypes. Genome-wide association studies (GWAS) were performed against average infusion rates in two cohorts: phase I ( n = 1205) and phase II ( n = 329). Top genetic variants identified from the meta-analysis were further examined to see if they could differentiate subgroups identified by k -means clustering. Three subgroups of patients with different response to phenylephrine were clustered and characterized: resistant (high infusion rate yet low mean systolic blood pressure (SBP)), intermediate (low infusion rate and low SBP), and sensitive (low infusion rate with high SBP). Differences among clusters were tabulated to assess for possible confounding influences. Comorbidity hierarchical clustering showed the resistant group had a higher prevalence of confounding factors than the intermediate and sensitive groups although overall prevalence is below 6%. Three loci with P < 1 × 10 −6 were associated with phenylephrine infusion rate. Only rs11572377 with P = 6.09 × 10 −7 , a 3′UTR variant of EDN2 , encoding a secretory vasoconstricting peptide, could significantly differentiate resistant from sensitive groups ( P = 0.015 and 0.018 for phase I and phase II) or resistant from pooled sensitive and intermediate groups ( P = 0.047 and 0.018). Retrospective analysis of electronic anesthetic records data coupled with the genetic data identified genetic variants contributing to variable sensitivity to phenylephrine infusion during anesthesia. Although the identified top gene, EDN2 , has robust biological relevance to vasoconstriction by binding to endothelin type A (ET A ) receptors on arterial smooth muscle cells, further functional as well as replication studies are necessary to confirm this association.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2019) conducted an observational in Intraoperative hypotension requiring phenylephrine (n=4,033). rs11572377 variant in EDN2 vs. Non-carriers / Reference genotype was evaluated on Phenylephrine average infusion rate (Beta 13.00, 95% CI 7.89-18.11, p=6.09 × 10-7). The rs11572377 variant in the EDN2 gene was associated with higher phenylephrine infusion rates and differentiated patients resistant to phenylephrine from sensitive patients.
Synapse has enriched 10 related papers. Consider them for comparative context: